JP Morgan Chase’s AdaptHealth AHCO Stock Holding History
Bought
Maintained
Sold
Other funds holding AHCO
JP Morgan Chase's AHCO Position: Q3 2026 in Review
JP Morgan Chase reduced its AdaptHealth (AHCO) stake by 22% in Q3 2026, selling an estimated $214K and leaving 102,730 shares worth $609K. The position accounts for ﹤0.01% of the portfolio, ranked #5084.
JP Morgan Chase first reported a position in AHCO in Q2 2020 and has held it in 26 quarters since. The position peaked at $35.1M in Q1 2021. 248 funds tracked by Wall St. Rank hold AHCO as of Q3 2026.
- JP Morgan Chase held 102,730 shares of AdaptHealth worth $609K as of Q3 2026.
- JP Morgan Chase sold 28,422 AdaptHealth shares in Q3 2026, an estimated $214K.
- AdaptHealth made up ﹤0.01% of JP Morgan Chase's portfolio in Q3 2026, its #5084 holding.
- JP Morgan Chase first reported a position in AdaptHealth in Q2 2020 and has held it in 26 quarters since.
- JP Morgan Chase's AdaptHealth position peaked at $35.1M in Q1 2021.
- 248 funds tracked by Wall St. Rank held AdaptHealth as of Q3 2026.
Based on JP Morgan Chase's 13F filing for Q3 2026, filed 12 Nov 2026.